By Fineline Cube 
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced receiving clearance from China’s National Medical Products Administration (NMPA) for its Toumai endoscopic surgery robot. The approval enables remote application across all surgical departments, marking the product as the world’s first laparoscopic surgical robot approved for such use.
Innovative Remote Surgical Technology
The Toumai endoscopic surgery robot leverages cutting-edge technology compatible with multiple communication networks. This enables low-latency master-slave control, high-bandwidth communication, and a high-stability system architecture. Since pioneering the world’s first 5G ultra-remote surgery in June 2022, Toumai has facilitated nearly 400 multi-department remote surgeries across Asia, the Americas, and Africa, achieving a 100% success rate and setting over 40 national and world records.-Fineline Info & Tech